Human Chorionic Gonadotropin Market

Human chorionic gonadotropin (HCG) is a female hormone produced by the placenta after implantation of the egg, which is why it can be detected in a few pregnancy tests. In addition, it can be extracted from the urine of pregnant women or produced from cultures of genetically modified cells using recombinant DNA technology.

Human Chorionic Gonadotropin Market contains market size and forecasts of Human Chorionic Gonadotropin (HCG) in global, including the following market information:

Global Human Chorionic Gonadotropin (HCG) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Human Chorionic Gonadotropin (HCG) Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Human Chorionic Gonadotropin (HCG) companies in 2021 (%)

The global Human Chorionic Gonadotropin (HCG) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Natural Source Extraction Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Human Chorionic Gonadotropin (HCG) include EMD Serono, Inc, Ferring B.V, Merck & Co., Inc, Bristol Myers Squibb Company, Fresenius Kabi AG, LLC, Scrippslabs, Leebio, Kamiya Biomedical Company and Sanzyme and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Human Chorionic Gonadotropin (HCG) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Human Chorionic Gonadotropin (HCG) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Human Chorionic Gonadotropin (HCG) Market Segment Percentages, by Type, 2021 (%)

• Natural Source Extraction
• Recombinant DNA Technology

Global Human Chorionic Gonadotropin (HCG) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Human Chorionic Gonadotropin (HCG) Market Segment Percentages, by Application, 2021 (%)

• Female Infertility Treatment
• Oligospermic Treatment
• Cryptorchidism Treatment
• Others

Global Human Chorionic Gonadotropin (HCG) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Human Chorionic Gonadotropin (HCG) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Human Chorionic Gonadotropin (HCG) revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Human Chorionic Gonadotropin (HCG) revenues share in global market, 2021 (%)
• Key companies Human Chorionic Gonadotropin (HCG) sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Human Chorionic Gonadotropin (HCG) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• EMD Serono, Inc
• Ferring B.V
• Merck & Co., Inc
• Bristol Myers Squibb Company
• Fresenius Kabi AG, LLC
• Scrippslabs
• Leebio
• Kamiya Biomedical Company
• Sanzyme
• Cigna